- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00513747
Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
A Phase III Intergroup CLL Study of Asymptomatic Patients With Untreated Chronic Lymphocytic Leukemia Randomized to Early Intervention Versus Observation With Later Treatment in the High Risk Genetic Subset With IGVH Unmutated Disease
RATIONALE: Drugs used in chemotherapy, such as fludarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Giving fludarabine together with rituximab may kill more cancer cells. Sometimes the cancer may not need treatment until it progresses. In this case, observation may be sufficient. It is not yet known whether giving fludarabine together with rituximab early is more effective than giving fludarabine and rituximab after observation in treating chronic lymphocytic leukemia.
PURPOSE: This randomized phase III trial is studying fludarabine and rituximab to compare how well they work when given early or after observation in treating patients with previously untreated chronic lymphocytic leukemia.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
OBJECTIVES:
Primary
- To determine if early treatment with chemoimmunotherapy comprising fludarabine phosphate and rituximab extends the time to second treatment in patients with genetically high-risk (unmutated IgV_H), asymptomatic, previously untreated chronic lymphocytic leukemia (CLL).
- To determine the time to disease progression that would warrant second treatment.
- To determine overall survival.
Secondary
- To measure the proportion of patients with asymptomatic, previously untreated CLL who have mutated and unmutated IgV_H genes.
- To determine the differences in acute and chronic toxicity of administering chemoimmunotherapy early to patients with genetically high-risk CLL compared to waiting until symptoms develop.
- To determine the effect of select pretreatment clinical and biological characteristics (such as interphase cytogenetic abnormalities, ZAP-70 expression, and p53 dysfunction [primary and secondary]) on response, time to second treatment, and overall survival of patients with genetically high-risk CLL randomized to early treatment.
- To determine the effect of select pretreatment clinical and biological characteristics (such as interphase cytogenetic abnormalities, ZAP-70 expression, and p53 dysfunction) on response, time to first and second treatments, and overall survival of patients with genetically high-risk CLL randomized to standard treatment (observation until symptoms occur).
- To describe the natural history of patients with genetically low-risk (mutated IgV_H genes), asymptomatic, previously untreated CLL, in terms of time to initial treatment, response, progression, and survival.
- To determine the effect of select pretreatment characteristics on time to first treatment, response, progression, and survival of patients with genetically low-risk CLL.
- To correlate patterns of resistance that emerge in patients with unmutated IgV_H genes who have relapsing or refractory CLL following receipt of chemoimmunotherapy with clonal evolution, including acquisition of high-risk karyotype abnormalities, p53 mutations, p53 dysfunction (primary and secondary), altered mRNA and protein expression related to treatment resistance, DNA mutations, microRNA gene expression, and methylation changes.
- To determine whether highly sensitive flow cytometry negativity at completion of therapy in patients randomized to early treatment is an effective surrogate marker for prolonged time to second treatment, overall survival, and other clinical benefits.
- To collect demographic data on familial CLL in newly diagnosed patients participating on this study.
OUTLINE: This is a multicenter study.
Genetically high-risk disease: Patients are stratified according to age (< 50 years vs 50 to 70 years vs > 70 years) and presence of the high-risk genetic feature [del(11)(q22.3) or del(17)(p13.1)] by FISH (yes vs no). Patients are randomized to 1 of 2 treatment arms.
- Arm I: Patients receive rituximab IV over 4 hours on days 1, 3, and 5 of week 1 and then on day 1 of weeks 5, 9, 13, 17, and 21. Patients also receive fludarabine phosphate IV over 30 minutes on days 1-5 of weeks 1, 5, 9, 13, 17, and 21. After completion of chemoimmunotherapy, patients are followed every 3 months until disease progression. At the time of disease progression, patients receive retreatment with chemoimmunotherapy as above or another treatment regimen.
- Arm II: Patients are followed every 3 months until disease progression. At the time of disease progression, patients receive rituximab and fludarabine phosphate as in arm I. Patients are then followed every 3 months until second disease progression. Patients with a second disease progression receive retreatment with chemoimmunotherapy as above or another treatment regimen.
- Genetically low-risk disease: Patients are followed every 3 months until disease progression. At the time of disease progression, patients receive rituximab and fludarabine phosphate as in arm I. Patients are then followed every 3 months until second disease progression. Patients with a second disease progression receive retreatment with chemoimmunotherapy as above or another treatment regimen.
Patients undergo blood sample collection periodically for correlative studies.
After finishing treatment, patients are followed periodically.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3E 0V9
- CancerCare Manitoba
-
-
New Brunswick
-
Moncton, New Brunswick, Canada, E1C 6Z8
- Moncton Hospital
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 1V8
- Nova Scotia Cancer Centre
-
-
Ontario
-
Hamilton, Ontario, Canada, L8V 5C2
- Margaret and Charles Juravinski Cancer Centre
-
Sudbury, Ontario, Canada, P3E 5J1
- Northeastern Ontario Regional Cancer Centre
-
Toronto, Ontario, Canada, M4N 3M5
- Edmond Odette Cancer Centre at Sunnybrook
-
-
Quebec
-
Montreal, Quebec, Canada, H1T 2M4
- Maisonneuve-Rosemont Hospital
-
-
Saskatchewan
-
Regina, Saskatchewan, Canada, S4T 7T1
- Allan Blair Cancer Centre at Pasqua Hospital
-
-
-
-
Alabama
-
Anniston, Alabama, United States, 36202
- Regional Medical Center
-
Huntsville, Alabama, United States, 35805
- Clearview Cancer Institute
-
-
Arkansas
-
Fort Smith, Arkansas, United States, 72901
- Sparks Regional Medical Center
-
-
California
-
Burbank, California, United States, 91505
- Providence Saint Joseph Medical Center - Burbank
-
Fullerton, California, United States, 92835
- Virginia K. Crosson Cancer Center at St. Jude Medical Center
-
Modesto, California, United States, 95355
- Memorial Medical Center
-
Mountain View, California, United States, 94040
- Camino Medical Group - Treatment Center
-
Palo Alto, California, United States, 94301
- Palo Alto Medical Foundation
-
Sacramento, California, United States, 95817
- University of California Davis Cancer Center
-
San Diego, California, United States, 92120
- Kaiser Permanente Medical Office -Vandever Medical Office
-
-
Colorado
-
Aurora, Colorado, United States, 80012
- Aurora Presbyterian Hospital
-
Boulder, Colorado, United States, 80301-9019
- Boulder Community Hospital
-
Colorado Springs, Colorado, United States, 80933
- Penrose Cancer Center at Penrose Hospital
-
Denver, Colorado, United States, 80210
- Porter Adventist Hospital
-
Denver, Colorado, United States, 80220
- Rose Medical Center
-
Denver, Colorado, United States, 80218
- Presbyterian - St. Luke's Medical Center
-
Denver, Colorado, United States, 80204
- St. Anthony Central Hospital
-
Denver, Colorado, United States, 80218
- St. Joseph Hospital
-
Denver, Colorado, United States, 80224-2522
- CCOP - Colorado Cancer Research Program
-
Englewood, Colorado, United States, 80110
- Swedish Medical Center
-
Grand Junction, Colorado, United States, 81502
- St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
-
Greeley, Colorado, United States, 80631
- North Colorado Medical Center
-
Lone Tree, Colorado, United States, 80124
- Sky Ridge Medical Center
-
Longmont, Colorado, United States, 80501
- Hope Cancer Care Center at Longmont United Hospital
-
Loveland, Colorado, United States, 80539
- McKee Medical Center
-
Pueblo, Colorado, United States, 81004
- St. Mary - Corwin Regional Medical Center
-
Thornton, Colorado, United States, 80229
- North Suburban Medical Center
-
Wheat Ridge, Colorado, United States, 80033
- Exempla Lutheran Medical Center
-
-
Connecticut
-
Manchester, Connecticut, United States, 06040
- Manchester Memorial Hospital
-
-
Delaware
-
Lewes, Delaware, United States, 19958
- Tunnell Cancer Center at Beebe Medical Center
-
Newark, Delaware, United States, 19713
- CCOP - Christiana Care Health Services
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20007
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
-
Washington, District of Columbia, United States, 20307-5001
- Walter Reed Army Medical Center
-
-
Florida
-
Fort Lauderdale, Florida, United States, 33308
- Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital
-
Hollywood, Florida, United States, 33021
- Memorial Cancer Institute at Memorial Regional Hospital
-
Jupiter, Florida, United States, 33458
- Ella Milbank Foshay Cancer Center at Jupiter Medical Center
-
Miami Beach, Florida, United States, 33140
- CCOP - Mount Sinai Medical Center
-
Orlando, Florida, United States, 32803-1273
- Florida Hospital Cancer Institute at Florida Hospital Orlando
-
Orlando, Florida, United States, 32806
- M.D. Anderson Cancer Center at Orlando
-
Pensacola, Florida, United States, 32504
- Sacred Heart Cancer Center at Sacred Heart Hospital
-
Pensacola, Florida, United States, 32514
- West Florida Cancer Institute at West Florida Hospital - Pensacola
-
-
Georgia
-
Albany, Georgia, United States, 31701
- Phoebe Cancer Center at Phoebe Putney Memorial Hospital
-
Columbus, Georgia, United States, 31904
- John B. Amos Cancer Center
-
-
Idaho
-
Boise, Idaho, United States, 83712
- Mountain States Tumor Institute at St. Luke's Regional Medical Center
-
-
Illinois
-
Alton, Illinois, United States, 62002
- Saint Anthony's Hospital at Saint Anthony's Health Center
-
Berwyn, Illinois, United States, 60402
- Hematology Oncology Associates of Illinois - Berwyn
-
Bloomington, Illinois, United States, 61701
- Illinois CancerCare - Bloomington
-
Bloomington, Illinois, United States, 61701
- St. Joseph Medical Center
-
Canton, Illinois, United States, 61520
- Illinois CancerCare - Canton
-
Carthage, Illinois, United States, 62321
- Memorial Hospital
-
Carthage, Illinois, United States, 62321
- Illinois CancerCare - Carthage
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
Chicago, Illinois, United States, 60637-1470
- University of Chicago Cancer Research Center
-
Chicago, Illinois, United States, 60611-3013
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
-
Chicago, Illinois, United States, 60611
- Hematology and Oncology Associates
-
Elmhurst, Illinois, United States, 60126
- Elmhurst Memorial Hospital
-
Eureka, Illinois, United States, 61530
- Illinois CancerCare - Eureka
-
Eureka, Illinois, United States, 61530
- Eureka Community Hospital
-
Galesburg, Illinois, United States, 61401
- Illinois CancerCare - Galesburg
-
Galesburg, Illinois, United States, 61401
- Galesburg Cottage Hospital
-
Galesburg, Illinois, United States, 61401
- Galesburg Clinic, PC
-
Havana, Illinois, United States, 62644
- Mason District Hospital
-
Havana, Illinois, United States, 62644
- Illinois CancerCare - Havana
-
Highland Park, Illinois, United States, 60035
- Kellogg Cancer Care Center
-
Joliet, Illinois, United States, 60432
- Midwest Center for Hematology/Oncology
-
Kewanee, Illinois, United States, 61443
- Illinois CancerCare - Kewanee Clinic
-
Libertyville, Illinois, United States, 60048
- North Shore Oncology and Hematology Associates, Limited - Libertyville
-
Macomb, Illinois, United States, 61455
- Illinois CancerCare - Macomb
-
Macomb, Illinois, United States, 61455
- Mcdonough District Hospital
-
Maywood, Illinois, United States, 60153
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
-
Moline, Illinois, United States, 61265
-
Moline, Illinois, United States, 61265
- Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
-
Monmouth, Illinois, United States, 61462
- Illinois CancerCare - Monmouth
-
Monmouth, Illinois, United States, 61462
- OSF Holy Family Medical Center
-
Mount Vernon, Illinois, United States, 62864
- Good Samaritan Regional Health Center
-
Naperville, Illinois, United States, 60540
- Edward Hospital Cancer Center
-
Naperville, Illinois, United States, 60563
- La Grange Oncology Associates - Geneva
-
Niles, Illinois, United States, 60714
- Cancer Care and Hematology Specialists of Chicagoland - Niles
-
Normal, Illinois, United States, 61761
- Bromenn Regional Medical Center
-
Normal, Illinois, United States, 61761
- Community Cancer Center
-
Normal, Illinois, United States, 61761
- Illinois CancerCare - Community Cancer Center
-
Ottawa, Illinois, United States, 61350
- Community Hospital of Ottawa
-
Ottawa, Illinois, United States, 61350
- Oncology Hematology Associates of Central Illinois, PC - Ottawa
-
Pekin, Illinois, United States, 61554
- Cancer Treatment Center at Pekin Hospital
-
Pekin, Illinois, United States, 61603
- Illinois CancerCare - Pekin
-
Peoria, Illinois, United States, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, United States, 61614
- Proctor Hospital
-
Peoria, Illinois, United States, 61637
- OSF St. Francis Medical Center
-
Peoria, Illinois, United States, 61615
- CCOP - Illinois Oncology Research Association
-
Peoria, Illinois, United States, 61615
- Oncology Hematology Associates of Central Illinois, PC - Peoria
-
Peru, Illinois, United States, 61354
- Illinois CancerCare - Peru
-
Peru, Illinois, United States, 61354
- Illinois Valley Community Hospital
-
Princeton, Illinois, United States, 61356
- Perry Memorial Hospital
-
Princeton, Illinois, United States, 61356
- Illinois CancerCare - Princeton
-
Rockford, Illinois, United States, 61104-2315
- Swedish-American Regional Cancer Center
-
Skokie, Illinois, United States, 60076
- Hematology Oncology Associates - Skokie
-
Spring Valley, Illinois, United States, 61362
- Illinois CancerCare - Spring Valley
-
Spring Valley, Illinois, United States, 61362
- St. Margaret's Hospital
-
Winfield, Illinois, United States, 60190
- Central Dupage Cancer Center
-
-
Indiana
-
Beech Grove, Indiana, United States, 46107
- St. Francis Hospital and Health Centers - Beech Grove Campus
-
Munster, Indiana, United States, 46321
- Community Hospital
-
Richmond, Indiana, United States, 47374
- Reid Hospital & Health Care Services
-
-
Iowa
-
Ames, Iowa, United States, 50010
- McFarland Clinic, PC
-
Bettendorf, Iowa, United States, 52722
-
Bettendorf, Iowa, United States, 52722
- Hematology Oncology Associates of the Quad Cities
-
Clive, Iowa, United States, 50325
- Medical Oncology and Hematology Associates - West Des Moines
-
Davenport, Iowa, United States, 52804
- Genesis Medical Center - West Campus
-
Davenport, Iowa, United States, 52803
- Genesis Regional Cancer Center at Genesis Medical Center
-
Des Moines, Iowa, United States, 50309
- CCOP - Iowa Oncology Research Association
-
Des Moines, Iowa, United States, 50309
- John Stoddard Cancer Center at Iowa Methodist Medical Center
-
Des Moines, Iowa, United States, 50309
- Medical Oncology and Hematology Associates at John Stoddard Cancer Center
-
Des Moines, Iowa, United States, 50314
- Medical Oncology and Hematology Associates at Mercy Cancer Center
-
Des Moines, Iowa, United States, 50314
- Mercy Cancer Center at Mercy Medical Center - Des Moines
-
Des Moines, Iowa, United States, 50316
- John Stoddard Cancer Center at Iowa Lutheran Hospital
-
Des Moines, Iowa, United States, 50307
- Mercy Capitol Hospital
-
Iowa City, Iowa, United States, 52242-1002
- Holden Comprehensive Cancer Center at University of Iowa
-
Iowa City, Iowa, United States, 52246
- Veterans Affairs Medical Center - Iowa City
-
Sioux City, Iowa, United States, 51101
- Siouxland Hematology-Oncology Associates, LLP
-
Sioux City, Iowa, United States, 51104
- St. Luke's Regional Medical Center
-
Sioux City, Iowa, United States, 51104
- Mercy Medical Center - Sioux City
-
Waterloo, Iowa, United States, 50702
- Covenant Cancer Treatment Center
-
Waterloo, Iowa, United States, 50701
- Cedar Valley Medical Specialists, PC - West Ridgeway Avenue
-
-
Kansas
-
Chanute, Kansas, United States, 66720
- Cancer Center of Kansas, PA - Chanute
-
Dodge City, Kansas, United States, 67801
- Cancer Center of Kansas, PA - Dodge City
-
El Dorado, Kansas, United States, 67042
- Cancer Center of Kansas, PA - El Dorado
-
Fort Scott, Kansas, United States, 66701
- Cancer Center of Kansas - Fort Scott
-
Independence, Kansas, United States, 67301
- Cancer Center of Kansas-Independence
-
Kingman, Kansas, United States, 67068
- Cancer Center of Kansas, PA - Kingman
-
Lawrence, Kansas, United States, 66044
- Lawrence Memorial Hospital
-
Liberal, Kansas, United States, 67901
- Southwest Medical Center
-
Newton, Kansas, United States, 67114
- Cancer Center of Kansas, PA - Newton
-
Overland Park, Kansas, United States, 66209
- Menorah Medical Center
-
Overland Park, Kansas, United States, 66213
- Saint Luke's Hospital - South
-
Parsons, Kansas, United States, 67357
- Cancer Center of Kansas, PA - Parsons
-
Pratt, Kansas, United States, 67124
- Cancer Center of Kansas, PA - Pratt
-
Salina, Kansas, United States, 67042
- Cancer Center of Kansas, PA - Salina
-
Shawnee Mission, Kansas, United States, 66204
- Shawnee Mission Medical Center
-
Topeka, Kansas, United States, 66606
- Cotton-O'Neil Cancer Center
-
Wellington, Kansas, United States, 67152
- Cancer Center of Kansas, PA - Wellington
-
Wichita, Kansas, United States, 67214
- Wesley Medical Center
-
Wichita, Kansas, United States, 67208
- Cancer Center of Kansas, PA - Medical Arts Tower
-
Wichita, Kansas, United States, 67214
- Cancer Center of Kansas, PA - Wichita
-
Wichita, Kansas, United States, 67214
- CCOP - Wichita
-
Wichita, Kansas, United States, 67214
- Via Christi Cancer Center at Via Christi Regional Medical Center
-
Wichita, Kansas, United States, 67208
- Associates in Womens Health, PA - North Review
-
Winfield, Kansas, United States, 67156
- Cancer Center of Kansas, PA - Winfield
-
-
Maine
-
Bangor, Maine, United States, 04401
- CancerCare of Maine at Eastern Maine Medical Center
-
Waterville, Maine, United States, 04901
- MaineGeneral Medical Center - Waterville
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- Greenebaum Cancer Center at University of Maryland Medical Center
-
Elkton, Maryland, United States, 21921
- Union Hospital Cancer Program at Union Hospital
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
Boston, Massachusetts, United States, 02115
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
-
Boston, Massachusetts, United States, 02115
- Dana-Farber/Brigham and Women's Cancer Center
-
Burlington, Massachusetts, United States, 01805
- Lahey Clinic Medical Center - Burlington
-
-
Michigan
-
Adrian, Michigan, United States, 49221
- Hickman Cancer Center at Bixby Medical Center
-
Ann Arbor, Michigan, United States, 48106-0995
- Saint Joseph Mercy Cancer Center
-
Ann Arbor, Michigan, United States, 48106
- CCOP - Michigan Cancer Research Consortium
-
Dearborn, Michigan, United States, 48123-2500
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
-
Escanaba, Michigan, United States, 49431
- Green Bay Oncology, Limited - Escanaba
-
Flint, Michigan, United States, 48503
- Hurley Medical Center
-
Flint, Michigan, United States, 48503
- Genesys Hurley Cancer Institute
-
Grosse Pointe Woods, Michigan, United States, 48236
- Van Elslander Cancer Center at St. John Hospital and Medical Center
-
Iron Mountain, Michigan, United States, 49801
- Dickinson County Healthcare System
-
Jackson, Michigan, United States, 49201
- Foote Memorial Hospital
-
Kalamazoo, Michigan, United States, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, United States, 49001
- Borgess Medical Center
-
Kalamazoo, Michigan, United States, 49007-3731
- West Michigan Cancer Center
-
Lambertville, Michigan, United States, 48144
- Haematology-Oncology Associates of Ohio and Michigan, PC
-
Lansing, Michigan, United States, 48912-1811
- Sparrow Regional Cancer Center
-
Livonia, Michigan, United States, 48154
- St. Mary Mercy Hospital
-
Monroe, Michigan, United States, 48162
- Community Cancer Center of Monroe
-
Monroe, Michigan, United States, 48162
- Mercy Memorial Hospital - Monroe
-
Pontiac, Michigan, United States, 48341-2985
- St. Joseph Mercy Oakland
-
Port Huron, Michigan, United States, 48060
- Mercy Regional Cancer Center at Mercy Hospital
-
Saginaw, Michigan, United States, 48601
- Seton Cancer Institute at Saint Mary's - Saginaw
-
Saint Joseph, Michigan, United States, 49085
- Oncology Care Associates, PLLC
-
Southfield, Michigan, United States, 48075
- Providence Cancer Institute at Providence Hospital - Southfield Campus
-
Warren, Michigan, United States, 48093
- St. John Macomb Hospital
-
-
Minnesota
-
Alexandria, Minnesota, United States, 56308
-
Burnsville, Minnesota, United States, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, United States, 55433
- Mercy and Unity Cancer Center at Mercy Hospital
-
Edina, Minnesota, United States, 55435
- Fairview Southdale Hospital
-
Fridley, Minnesota, United States, 55432
- Mercy and Unity Cancer Center at Unity Hospital
-
Hutchinson, Minnesota, United States, 55350
- Hutchinson Area Health Care
-
Maplewood, Minnesota, United States, 55109
- Minnesota Oncology Hematology, PA - Maplewood
-
Maplewood, Minnesota, United States, 55109
- HealthEast Cancer Care at St. John's Hospital
-
Minneapolis, Minnesota, United States, 55417
- Veterans Affairs Medical Center - Minneapolis
-
Minneapolis, Minnesota, United States, 55407
- Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
-
Minneapolis, Minnesota, United States, 55415
- Hennepin County Medical Center - Minneapolis
-
Robbinsdale, Minnesota, United States, 55422-2900
- Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic Cancer Center
-
Saint Cloud, Minnesota, United States, 56303
- CentraCare Clinic - River Campus
-
Saint Cloud, Minnesota, United States, 56303
- Coborn Cancer Center
-
Saint Louis Park, Minnesota, United States, 55416
- CCOP - Metro-Minnesota
-
Saint Louis Park, Minnesota, United States, 55416
- Park Nicollet Cancer Center
-
Saint Paul, Minnesota, United States, 55102
- United Hospital
-
Saint Paul, Minnesota, United States, 55101
- Regions Hospital Cancer Care Center
-
Shakopee, Minnesota, United States, 55379
- St. Francis Cancer Center at St. Francis Medical Center
-
Waconia, Minnesota, United States, 55387
- Ridgeview Medical Center
-
Woodbury, Minnesota, United States, 55125
- Minnesota Oncology Hematology, PA - Woodbury
-
-
Missouri
-
Cape Girardeau, Missouri, United States, 63703
- Saint Francis Medical Center
-
Kansas City, Missouri, United States, 64131
- CCOP - Kansas City
-
Kansas City, Missouri, United States, 64116
- North Kansas City Hospital
-
Kansas City, Missouri, United States, 64132
- Research Medical Center
-
Kansas City, Missouri, United States, 64108
- Truman Medical Center - Hospital Hill
-
Kansas City, Missouri, United States, 64111
- Saint Luke's Cancer Institute at Saint Luke's Hospital
-
Kansas City, Missouri, United States, 64114
- St. Joseph Medical Center
-
Kansas City, Missouri, United States, 64116
- Parvin Radiation Oncology
-
Lee's Summit, Missouri, United States, 64086
- Saint Luke's East - Lee's Summit
-
Liberty, Missouri, United States, 64068
- Liberty Hospital
-
Saint Joseph, Missouri, United States, 64506
- Heartland Regional Medical Center
-
Saint Louis, Missouri, United States, 63141
- CCOP - St. Louis-Cape Girardeau
-
Saint Louis, Missouri, United States, 63110
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
-
Saint Louis, Missouri, United States, 63110
- Saint Louis University Cancer Center
-
Saint Louis, Missouri, United States, 63109
- Midwest Hematology Oncology Group, Incorporated
-
Saint Louis, Missouri, United States, 63141
- David C. Pratt Cancer Center at St. John's Mercy
-
Springfield, Missouri, United States, 65802
- CCOP - Cancer Research for the Ozarks
-
Springfield, Missouri, United States, 65804
- St. John's Regional Health Center
-
Springfield, Missouri, United States, 65807
- Hulston Cancer Center at Cox Medical Center South
-
-
Montana
-
Billings, Montana, United States, 59101
- CCOP - Montana Cancer Consortium
-
Billings, Montana, United States, 59101
- Hematology-Oncology Centers of the Northern Rockies - Billings
-
Billings, Montana, United States, 59101
- Northern Rockies Radiation Oncology Center
-
Billings, Montana, United States, 59101
- St. Vincent Healthcare Cancer Care Services
-
Billings, Montana, United States, 59107-7000
- Billings Clinic - Downtown
-
Bozeman, Montana, United States, 59715
- Bozeman Deaconess Cancer Center
-
Butte, Montana, United States, 59701
- St. James Healthcare Cancer Care
-
Great Falls, Montana, United States, 59405
- Great Falls Clinic - Main Facility
-
Great Falls, Montana, United States, 59405
-
Great Falls, Montana, United States, 59405-5309
- Big Sky Oncology
-
Great Falls, Montana, United States, 59405
- Sletten Cancer Institute at Benefis Healthcare
-
Havre, Montana, United States, 59501
- Northern Montana Hospital
-
Helena, Montana, United States, 59601
- St. Peter's Hospital
-
Kalispell, Montana, United States, 59901
- Kalispell Regional Medical Center
-
Kalispell, Montana, United States, 59901
- Glacier Oncology, PLLC
-
Kalispell, Montana, United States, 59901
- Kalispell Medical Oncology at KRMC
-
Missoula, Montana, United States, 59801
- Community Medical Center
-
Missoula, Montana, United States, 59804
- Guardian Oncology and Center for Wellness
-
Missoula, Montana, United States, 59807-7877
- Montana Cancer Specialists at Montana Cancer Center
-
Missoula, Montana, United States, 59807
- Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
-
-
Nebraska
-
Omaha, Nebraska, United States, 68106
- CCOP - Missouri Valley Cancer Consortium
-
Omaha, Nebraska, United States, 68122
- Immanuel Medical Center
-
Omaha, Nebraska, United States, 68124
- Alegant Health Cancer Center at Bergan Mercy Medical Center
-
Omaha, Nebraska, United States, 68131-2197
- Creighton University Medical Center
-
Omaha, Nebraska, United States, 68114
- Methodist Estabrook Cancer Center
-
-
New Jersey
-
East Orange, New Jersey, United States, 07018-1095
- Veterans Affairs Medical Center - East Orange
-
Flemington, New Jersey, United States, 08822
- Hunterdon Regional Cancer Center at Hunterdon Medical Center
-
Marlton, New Jersey, United States, 08053
- Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
-
Voorhees, New Jersey, United States, 08043
- Cancer Institute of New Jersey at Cooper - Voorhees
-
Voorhees, New Jersey, United States, 08043
- Fox Chase Virtua Health Cancer Program at Virtua West Jersey
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87131-5636
- University of New Mexico Cancer Center
-
Santa Fe, New Mexico, United States, 87505
- New Mexico Cancer Care Associates
-
-
New York
-
East Syracuse, New York, United States, 13057
- CCOP - Hematology-Oncology Associates of Central New York
-
Glens Falls, New York, United States, 12801
- Adirondack Cancer Care - Glens Falls
-
Lake Success, New York, United States, 11042
- Monter Cancer Center of the North Shore-LIJ Health System
-
Manhasset, New York, United States, 11030
- CCOP - North Shore University Hospital
-
Manhasset, New York, United States, 11030
- Don Monti Comprehensive Cancer Center at North Shore University Hospital
-
New Hyde Park, New York, United States, 11040
- Long Island Jewish Medical Center
-
New York, New York, United States, 10021
- New York Weill Cornell Cancer Center at Cornell University
-
Rochester, New York, United States, 14642
- James P. Wilmot Cancer Center at University of Rochester Medical Center
-
Stony Brook, New York, United States, 11794-9446
- Stony Brook University Cancer Center
-
Syracuse, New York, United States, 13210
- Veterans Affairs Medical Center - Syracuse
-
Syracuse, New York, United States, 13210
- SUNY Upstate Medical University Hospital
-
-
North Carolina
-
Asheville, North Carolina, United States, 28801
- Mission Hospitals - Memorial Campus
-
Concord, North Carolina, United States, 28025
- Batte Cancer Center at Northeast Medical Center
-
Goldsboro, North Carolina, United States, 27534
- Wayne Memorial Hospital, Incorporated
-
Hendersonville, North Carolina, United States, 28791
- Pardee Memorial Hospital
-
Kinston, North Carolina, United States, 28501
- Kinston Medical Specialists
-
Winston-Salem, North Carolina, United States, 27157-1096
- Wake Forest University Comprehensive Cancer Center
-
-
North Dakota
-
Bismarck, North Dakota, United States, 58501
- Bismarck Cancer Center
-
Bismarck, North Dakota, United States, 58501
- Medcenter One Hospital Cancer Care Center
-
Bismarck, North Dakota, United States, 58501
- Mid Dakota Clinic, PC
-
Bismarck, North Dakota, United States, 58502
- St. Alexius Medical Center Cancer Center
-
-
Ohio
-
Akron, Ohio, United States, 44309-2090
- Summa Center for Cancer Care at Akron City Hospital
-
Bellefontaine, Ohio, United States, 43311
- Mary Rutan Hospital
-
Bowling Green, Ohio, United States, 43402
- Wood County Oncology Center
-
Chillicothe, Ohio, United States, 45601
- Adena Regional Medical Center
-
Cleveland, Ohio, United States, 44109
- MetroHealth Cancer Care Center at MetroHealth Medical Center
-
Clyde, Ohio, United States, 43410
- North Coast Cancer Care - Clyde
-
Columbus, Ohio, United States, 43214-3998
- Riverside Methodist Hospital Cancer Care
-
Columbus, Ohio, United States, 43222
- Mount Carmel Health - West Hospital
-
Columbus, Ohio, United States, 43210-1240
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
-
Columbus, Ohio, United States, 43215
- CCOP - Columbus
-
Columbus, Ohio, United States, 43215
- Grant Medical Center Cancer Care
-
Columbus, Ohio, United States, 43228
- Doctors Hospital at Ohio Health
-
Dayton, Ohio, United States, 45405
- Grandview Hospital
-
Dayton, Ohio, United States, 45406
- Good Samaritan Hospital
-
Dayton, Ohio, United States, 45409
- David L. Rike Cancer Center at Miami Valley Hospital
-
Dayton, Ohio, United States, 45415
- Samaritan North Cancer Care Center
-
Dayton, Ohio, United States, 45420
- CCOP - Dayton
-
Delaware, Ohio, United States, 43015
- Grady Memorial Hospital
-
Elyria, Ohio, United States, 44035
- Hematology Oncology Center
-
Findlay, Ohio, United States, 45840
- Blanchard Valley Medical Associates
-
Franklin, Ohio, United States, 45005-1066
- Middletown Regional Hospital
-
Greenville, Ohio, United States, 45331
- Wayne Hospital
-
Kettering, Ohio, United States, 45429
- Charles F. Kettering Memorial Hospital
-
Lancaster, Ohio, United States, 43130
- Fairfield Medical Center
-
Lima, Ohio, United States, 45804
- Lima Memorial Hospital
-
Lima, Ohio, United States, 45801
- St. Rita's Medical Center
-
Marietta, Ohio, United States, 45750
- Strecker Cancer Center at Marietta Memorial Hospital
-
Maumee, Ohio, United States, 43537
- St. Luke's Hospital
-
Maumee, Ohio, United States, 43537-1839
- Northwest Ohio Oncology Center
-
Newark, Ohio, United States, 43055
- Licking Memorial Cancer Care Program at Licking Memorial Hospital
-
Oregon, Ohio, United States, 43616
- St. Charles Mercy Hospital
-
Oregon, Ohio, United States, 43616
- Toledo Clinic - Oregon
-
Sandusky, Ohio, United States, 44870
- North Coast Cancer Care, Incorporated
-
Springfield, Ohio, United States, 45505
- Community Hospital of Springfield and Clark County
-
Springfield, Ohio, United States, 45504
- Mercy Medical Center
-
Sylvania, Ohio, United States, 43560
- Flower Hospital Cancer Center
-
Tiffin, Ohio, United States, 44883
- Mercy Hospital of Tiffin
-
Toledo, Ohio, United States, 43608
- St. Vincent Mercy Medical Center
-
Toledo, Ohio, United States, 43606
- Toledo Hospital
-
Toledo, Ohio, United States, 43614
- Medical University of Ohio Cancer Center
-
Toledo, Ohio, United States, 43617
- CCOP - Toledo Community Hospital
-
Toledo, Ohio, United States, 43623
- Toledo Clinic, Incorporated - Main Clinic
-
Toledo, Ohio, United States, 43623
- St. Anne Mercy Hospital
-
Troy, Ohio, United States, 45373-1300
- UVMC Cancer Care Center at Upper Valley Medical Center
-
Wauseon, Ohio, United States, 43567
- Fulton County Health Center
-
Westerville, Ohio, United States, 43081
- Mount Carmel St. Ann's Cancer Center
-
Wilmington, Ohio, United States, 45177
- Clinton Memorial Hospital
-
Xenia, Ohio, United States, 45385
- Ruth G. McMillan Cancer Center at Greene Memorial Hospital
-
Zanesville, Ohio, United States, 43701
- Genesis - Good Samaritan Hospital
-
-
Oregon
-
Milwaukie, Oregon, United States, 97222
- Providence Milwaukie Hospital
-
Portland, Oregon, United States, 97213-2967
- Providence Cancer Center at Providence Portland Medical Center
-
Portland, Oregon, United States, 97225
- CCOP - Columbia River Oncology Program
-
Portland, Oregon, United States, 97225
- Providence St. Vincent Medical Center
-
Portland, Oregon, United States, 97232
- Kaiser Permanente Health Care - Portland
-
Tualatin, Oregon, United States, 97062
- Legacy Meridian Park Hospital
-
-
Pennsylvania
-
Danville, Pennsylvania, United States, 17822-0001
- Geisinger Cancer Institute at Geisinger Health
-
Hazleton, Pennsylvania, United States, 18201
- Geisinger Hazleton Cancer Center
-
Media, Pennsylvania, United States, 19063
- Riddle Memorial Hospital Cancer Center
-
Philadelphia, Pennsylvania, United States, 19107-5541
- Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
-
Philadelphia, Pennsylvania, United States, 19107
- Joan Karnell Cancer Center at Pennsylvania Hospital
-
Phoenixville, Pennsylvania, United States, 19460
- Cancer Center at Phoenixville Hospital
-
State College, Pennsylvania, United States, 16801
- Geisinger Medical Group - Scenery Park
-
Wilkes-Barre, Pennsylvania, United States, 18711
- Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
-
-
Rhode Island
-
Pawtucket, Rhode Island, United States, 02860
- Memorial Hospital of Rhode Island
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Hollings Cancer Center at Medical University of South Carolina
-
Florence, South Carolina, United States, 29501
- McLeod Regional Medical Center
-
Greenville, South Carolina, United States, 29615
- CCOP - Greenville
-
-
Vermont
-
Berlin, Vermont, United States, 05602
- Mountainview Medical
-
Burlington, Vermont, United States, 05401
- Fletcher Allen Health Care - University Health Center Campus
-
-
Virginia
-
Fredericksburg, Virginia, United States, 22401
- Fredericksburg Oncology, Incorporated
-
-
Washington
-
Bellingham, Washington, United States, 98225
- St. Joseph Cancer Center
-
Bremerton, Washington, United States, 98310
- Olympic Hematology and Oncology
-
Kennewick, Washington, United States, 99336
- Columbia Basin Hematology
-
Poulsbo, Washington, United States, 98370
- Harrison Poulsbo Hematology and Onocology
-
Seattle, Washington, United States, 98104
- Minor and James Medical, PLLC
-
Seattle, Washington, United States, 98112
- Group Health Central Hospital
-
Seattle, Washington, United States, 98122-4307
- Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
-
Seattle, Washington, United States, 98122
- Polyclinic First Hill
-
Seattle, Washington, United States, 98195-6043
- University Cancer Center at University of Washington Medical Center
-
Spokane, Washington, United States, 99202
- Cancer Care Northwest - Spokane South
-
Spokane, Washington, United States, 99218
- Evergreen Hematology and Oncology, PS
-
Vancouver, Washington, United States, 98668
- Southwest Washington Medical Center Cancer Center
-
-
Wisconsin
-
Chippewa Falls, Wisconsin, United States, 54729
- Marshfield Clinic - Chippewa Center
-
Eau Claire, Wisconsin, United States, 54701
- Marshfield Clinic Cancer Care at Regional Cancer Center
-
Fond Du Lac, Wisconsin, United States, 54935
- Central Wisconsin Cancer Program at Agnesian HealthCare
-
Glendale, Wisconsin, United States, 53212-1038
- Oncology Alliance, SC - Milwaukee - East
-
Green Bay, Wisconsin, United States, 54307-3508
- St. Vincent Hospital Regional Cancer Center
-
Green Bay, Wisconsin, United States, 54301-3526
- Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
-
Green Bay, Wisconsin, United States, 54303
- Green Bay Oncology, Limited at St. Mary's Hospital
-
Green Bay, Wisconsin, United States, 54303
- St. Mary's Hospital Medical Center - Green Bay
-
Manitowoc, Wisconsin, United States, 54221-1450
- Holy Family Memorial Medical Center Cancer Care Center
-
Marinette, Wisconsin, United States, 54143
- Bay Area Cancer Care Center at Bay Area Medical Center
-
Marshfield, Wisconsin, United States, 54449
- Saint Joseph's Hospital
-
Marshfield, Wisconsin, United States, 54449
- Marshfield Clinic - Marshfield Center
-
Minocqua, Wisconsin, United States, 54548
- Marshfield Clinic - Lakeland Center
-
Oconomowoc, Wisconsin, United States, 53066
- Regional Cancer Center at Oconomowoc Memorial Hospital
-
Oconto Falls, Wisconsin, United States, 54154
- Green Bay Oncology, Limited - Oconto Falls
-
Rhinelander, Wisconsin, United States, 54501
- Ministry Medical Group at Saint Mary's Hospital
-
Rice Lake, Wisconsin, United States, 54868
- Marshfield Clinic - Indianhead Center
-
Sheboygan, Wisconsin, United States, 53081
- Vince Lombardi Cancer Clinic - Sheboygan
-
Stevens Point, Wisconsin, United States, 54481
- Saint Michael's Hospital Cancer Center
-
Sturgeon Bay, Wisconsin, United States, 54235
- Green Bay Oncology, Limited - Sturgeon Bay
-
Waukesha, Wisconsin, United States, 53188
- Waukesha Memorial Hospital Regional Cancer Center
-
Weston, Wisconsin, United States, 54476
- Marshfield Clinic - Weston Center
-
Wisconsin Rapids, Wisconsin, United States, 54494
- Marshfield Clinic - Wisconsin Rapids Center
-
-
Wyoming
-
Sheridan, Wyoming, United States, 82801
- Welch Cancer Center at Sheridan Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Eligibility Criteria for Pre-Registration:
- Patients must be within 6 months of the initial flow cytometric confirmation of B-cell chronic lymphocytic leukemia (CLL). This interval begins with the initial flow cytometric confirmation of disease.
Clinical and immunophenotypic evidence of CLL including:
2.1 An absolute lymphocytosis of > 5,000/μL
- Morphologically, the lymphocytes must appear mature with < 55% prolymphocytes.
- Local institution lymphocyte phenotype must reveal a predominant B-cell monoclonal population sharing a B-cell marker (CD19, CD20, CD23) with the CD5 antigen, in the absence of other pan-T-cell markers.
- Additionally, the B-cells must be monoclonal with regard to expression of either κ or λ and have surface immunoglobulin expression of low density.
- Patients with bright surface immunoglobulin levels must have CD23 coexpression and absence of t(11;14) on interphase cytogenetics or have negative tumor protein staining for cyclin D1.
2.2 Staging - Patients must be in the low category (i.e., only stages 0 or I) of the modified three-stage Rai staging system as described in the protocol.
Patients should not have evidence of active disease as demonstrated by any of the following criteria:
- Splenomegaly and/or massive/progressive lymphadenopathy that would require therapy
- Presence of weight loss > 10% over the preceding 6 month period
- Grade 2 or 3 fatigue
- Fevers > 100.5°F or night sweats for greater than 2 weeks without evidence of infection
- Progressive lymphocytosis with an increase of > 50% over a 2 month period or an anticipated doubling time of less than 6 months.
- Prior Treatment: No prior therapy for CLL including corticosteroids for autoimmune complications that have developed since the initial diagnosis of CLL.
- Age ≥ 18 years
- Performance Status 0 - 1.
- No HIV disease. Due to alterations in host immunity, patients known to have HIV infection may not be enrolled.
- Non-pregnant and non-nursing. Due to the unknown teratogenic potential of chemotherapy, pregnant or nursing women may not be enrolled. Women and men of reproductive potential should agree to use an effective means of birth control.
Required Initial Laboratory Values:
- Creatinine ≤ 1.5 x upper limit of normal
Eligibility Criteria for Registration (to Low-Risk Cohort or High-Risk Cohort Randomization between Early Intervention Versus Observation with Later Treatment)
- Successful determination of IgVH mutational status by reference laboratory.
Absence of progression of CLL, i.e., absence of the following:
- Progressive splenomegaly and/or lymphadenopathy on two independent measures spaced two weeks apart. If one assessment notes progression, this should be repeated prior to re-registration.
- Development of anemia (hemoglobin < 11 g/dL) or thrombocytopenia (platelets < 100,000/μL).
- Progressive lymphocytosis with an increase of > 50% over a 2 month period or an anticipated doubling time of less than 6 months.
- Symptoms referable to CLL, including weight loss > 10% over the preceding 6 month period; grade 2 or 3 fatigue; or fevers > 100.5°F and/or night sweats for greater than 2 weeks without evidence of infection.
Required Laboratory Value:
- Creatinine ≤ 1.5 x upper limit of normal
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm I
Patients receive rituximab IV over 4 hours on days 1, 3, and 5 of week 1 and then on day 1 of weeks 5, 9, 13, 17, and 21.
Patients also receive fludarabine phosphate IV over 30 minutes on days 1-5 of weeks 1, 5, 9, 13, 17, and 21.
After completion of chemoimmunotherapy, patients are followed every 3 months until disease progression.
At the time of disease progression, patients receive retreatment with chemoimmunotherapy as above or another treatment regimen.
|
Given IV over 4 hours
Given IV over 30 minutes
|
|
Active Comparator: Arm II
Patients are followed every 3 months until disease progression.
At the time of disease progression, patients receive rituximab and fludarabine phosphate as in arm I. Patients are then followed every 3 months until second disease progression.
Patients with a second disease progression receive retreatment with chemoimmunotherapy as above or another treatment regimen.
|
Given IV over 4 hours
Given IV over 30 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to Second Treatment in High Risk Patients
Time Frame: Up to 72 months
|
Kaplan-Meier analysis was conducted to estimate the distribution of time from randomization to second treatment or death whichever comes first.
Events were defined as the start of second treatment or death.
Patients who had not experienced one of these defined events of interest were censored at their last known follow-up.
|
Up to 72 months
|
|
Disease-Free Survival in High Risk Patients
Time Frame: Up to 72 months
|
Kaplan-Meier analysis was conducted to estimate disease free survival defined as:>
|
Up to 72 months
|
|
Overall Survival (OS) for High Risk Patients
Time Frame: Up to 72 months
|
Kaplan-Meier analysis was conducted to estimate the distribution of time from randomization to death from any cause.
Estimates were not stratified.
Patients who did not experience this primary outcome had their survival times censored at their last follow-up.
|
Up to 72 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Patients With Mutated and Unmutated IgVH Genes
Time Frame: Once at baseline
|
Number of patients with mutated and unmutated IgVH genes are reported below.
|
Once at baseline
|
|
Overall Survival in Low Risk Patients
Time Frame: Up to 72 months
|
Overall survival in low risk patients (registration to first treatment or death)> • Events were defined as death from any cause. Low risk Patients who were alive were censored at their last known follow-up. |
Up to 72 months
|
|
Time to First Treatment Survival in Low Risk Patients
Time Frame: Up to 72 months
|
Time to First Treatment Survival in low risk patients (registration to first treatment or death)> • Events were defined as the start of first treatment or death from any cause. Patients who didn't receive their first treatment were censored at their last known follow-up. |
Up to 72 months
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: John C. Byrd, MD, Ohio State University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Immune System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Lymphoproliferative Disorders
- Lymphatic Diseases
- Immunoproliferative Disorders
- Leukemia, B-Cell
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Antirheumatic Agents
- Antimetabolites, Antineoplastic
- Antimetabolites
- Antineoplastic Agents
- Immunosuppressive Agents
- Immunologic Factors
- Antineoplastic Agents, Immunological
- Rituximab
- Fludarabine
- Fludarabine phosphate
Other Study ID Numbers
- CALGB-10501
- U10CA031946 (U.S. NIH Grant/Contract)
- CDR0000537685 (Registry Identifier: NCI Physician Data Query)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Leukemia
-
Massachusetts General HospitalCelgene CorporationTerminatedAcute Myelogenous Leukemia | Acute Myeloid Leukemia (AML) | Acute Myelocytic Leukemia | Acute Granulocytic Leukemia | Acute Non-Lymphocytic LeukemiaUnited States
-
Institute of Hematology & Blood Diseases HospitalBejing Institute for Stem Cell and Regenerative Medicine; Institute for Stem...RecruitingRefractory Leukemia | Relapsed Leukemia | Acute Myeloid Leukemia, ChildhoodChina
-
Betta Pharmaceuticals Co., Ltd.Not yet recruitingAcute Myeloid Leukemia LeukemiaChina
-
Massachusetts General HospitalCompleted
-
Stanford UniversityTerminatedLeukemia | Leukemia, Lymphocytic, Acute | Leukemia Acute Promyelocytic Leukemia (APL) | Leukemia Acute Lymphoid Leukemia (ALL) | Leukemia Chronic Myelogenous Leukemia (CML) | Leukemia Acute Myeloid Leukemia (AML) | Leukemia Chronic Lymphocytic Leukemia (CLL)United States
-
National Cancer Institute (NCI)TerminatedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
Washington University School of MedicineWithdrawnRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
C. Babis AndreadisGateway for Cancer Research; AVEO Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Erythroleukemia (M6) | Childhood Acute Megakaryocytic Leukemia (M7) | Childhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia With Maturation (M2) | Childhood Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
PETHEMA FoundationRecruitingAcute Myeloblastic LeukemiaSpain
Clinical Trials on rituximab
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)TerminatedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular... and other conditionsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedEBV-Related Post-Transplant Lymphoproliferative Disorder | Monomorphic Post-Transplant Lymphoproliferative Disorder | Polymorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder | Recurrent Polymorphic Post-Transplant Lymphoproliferative... and other conditionsUnited States
-
PfizerCompletedRheumatoid ArthritisUnited States, Australia, Canada, Israel, Mexico, Colombia, Germany, Russian Federation, South Africa, United Kingdom
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Recurrent Chronic Lymphocytic LeukemiaUnited States
-
Mabion SAParexelWithdrawn
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingDLBCL - Diffuse Large B Cell Lymphoma
-
M.D. Anderson Cancer CenterActive, not recruitingMantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular LymphomaUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.Recruiting